SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease
Eur J Gastroenterol Hepatol
.
2022 Aug 1;34(8):883-884.
doi: 10.1097/MEG.0000000000002379.
Epub 2022 Jun 29.
Authors
Antonio Tursi
1
2
,
Loris Riccardo Lopetuso
3
4
5
,
Lorenzo Maria Vetrone
5
,
Antonio Gasbarrini
5
6
,
Alfredo Papa
5
6
Affiliations
1
Territorial Gastroenterology Service, ASL BAT, Andria.
2
Department of Medicine and Surgery, Post-Graduate School of Digestive Disease, Catholic University, Rome.
3
Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti- Pescara.
4
Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti.
5
CEMAD, Digestive Disease Center, Fondazione Policlinico A. Gemelli, IRCCS.
6
Department of Medicine and Surgery, Catholic University, Rome, Italy.
PMID:
35802531
PMCID:
PMC9245529
DOI:
10.1097/MEG.0000000000002379
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Inflammatory Bowel Diseases* / epidemiology
SARS-CoV-2